» Articles » PMID: 33287315

Iron: An Essential Element of Cancer Metabolism

Overview
Journal Cells
Publisher MDPI
Date 2020 Dec 8
PMID 33287315
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer cells undergo considerable metabolic changes to foster uncontrolled proliferation in a hostile environment characterized by nutrient deprivation, poor vascularization and immune infiltration. While metabolic reprogramming has been recognized as a hallmark of cancer, the role of micronutrients in shaping these adaptations remains scarcely investigated. In particular, the broad electron-transferring abilities of iron make it a versatile cofactor that is involved in a myriad of biochemical reactions vital to cellular homeostasis, including cell respiration and DNA replication. In cancer patients, systemic iron metabolism is commonly altered. Moreover, cancer cells deploy diverse mechanisms to increase iron bioavailability to fuel tumor growth. Although iron itself can readily participate in redox reactions enabling vital processes, its reactivity also gives rise to reactive oxygen species (ROS). Hence, cancer cells further rely on antioxidant mechanisms to withstand such stress. The present review provides an overview of the common alterations of iron metabolism occurring in cancer and the mechanisms through which iron promotes tumor growth.

Citing Articles

Zinc, copper, copper-to-zinc ratio, and other biometals in blood serum and tumor tissue of patients with colorectal cancer.

Skalny A, Kushlinskii N, Korobeinikova T, Alferov A, Kuzmin Y, Kochkina S Biometals. 2025; .

PMID: 39820949 DOI: 10.1007/s10534-024-00660-8.


Unraveling the causal relationship between serum minerals and pancreatic cancer: a Mendelian randomization study.

Liu C, Wu H, Cai D, Yu X Discov Oncol. 2024; 15(1):788.

PMID: 39692823 PMC: 11655719. DOI: 10.1007/s12672-024-01695-6.


Ampicillin-derived carbon dots as the sensitive probe for the detection of Fe and Cu in living cells and water samples.

Dong H, Xie H, Xie X, Wang Q, Sun H, Zhu W Mikrochim Acta. 2024; 191(12):759.

PMID: 39585453 DOI: 10.1007/s00604-024-06849-5.


Deferasirox's Anti-Chemoresistance and Anti-Metastatic Effect on Non-Small Cell Lung Carcinoma.

Delgado Y, Torres-Sanchez A, Perez D, Torres G, Estrada S, Ortiz Alvelo N Biomedicines. 2024; 12(10).

PMID: 39457585 PMC: 11505511. DOI: 10.3390/biomedicines12102272.


Identification of TFRC as a biomarker for pulmonary arterial hypertension based on bioinformatics and experimental verification.

Yang C, Liu Y, Zheng H Respir Res. 2024; 25(1):296.

PMID: 39097701 PMC: 11298087. DOI: 10.1186/s12931-024-02928-6.


References
1.
Nemeth E, Valore E, Territo M, Schiller G, Lichtenstein A, Ganz T . Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2002; 101(7):2461-3. DOI: 10.1182/blood-2002-10-3235. View

2.
Torti S, Torti F . Iron and Cancer: 2020 Vision. Cancer Res. 2020; 80(24):5435-5448. PMC: 8118237. DOI: 10.1158/0008-5472.CAN-20-2017. View

3.
Xing P, Liao Z, Ren Z, Zhao J, Song F, Wang G . Roles of low-density lipoprotein receptor-related protein 1 in tumors. Chin J Cancer. 2016; 35:6. PMC: 4704379. DOI: 10.1186/s40880-015-0064-0. View

4.
Swaminathan S, Fonseca V, Alam M, Shah S . The role of iron in diabetes and its complications. Diabetes Care. 2007; 30(7):1926-33. DOI: 10.2337/dc06-2625. View

5.
Ferrucci L, Cross A, Graubard B, Brinton L, McCarty C, Ziegler R . Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Br J Cancer. 2009; 101(1):178-84. PMC: 2713710. DOI: 10.1038/sj.bjc.6605118. View